Grifols, S.A Long-Term Investments 2012-2025 | GRFS

Grifols, S.A long-term investments for the quarter ending March 31, 2025 were $0.543B, a 80.3% decline year-over-year.

  • Grifols, S.A long-term investments for 2024 were $0.605B, a 21.4% decline from 2023.
  • Grifols, S.A long-term investments for 2023 were $0.77B, a 71.62% decline from 2022.
  • Grifols, S.A long-term investments for 2022 were $2.714B, a 2.88% decline from 2021.

Grifols, S.A Long-Term Investments 2012-2025 | GRFS

  • Grifols, S.A long-term investments for 2024 were $0.605B, a 21.4% decline from 2023.
  • Grifols, S.A long-term investments for 2023 were $0.77B, a 71.62% decline from 2022.
  • Grifols, S.A long-term investments for 2022 were $2.714B, a 2.88% decline from 2021.
Related Stocks
Company NameMarket
Cap
Chugai Pharmaceutical (CHGCY)$75.9B
Zoetis (ZTS)$67.3B
Takeda Pharmaceutical (TAK)$46.3B
Daiichi Sankyo, - (DSNKY)$45.5B
BeOne Medicines - (ONC)$32.4B
Sandoz Group AG (SDZNY)$25.8B
Summit Therapeutics (SMMT)$19.7B
Merck (MKKGY)$16.7B
Shionogi (SGIOY)$14B
United Therapeutics (UTHR)$13.4B
Neurocrine Biosciences (NBIX)$13.1B
Orion OYJ (ORINY)$11.7B
IPSEN (IPSEY)$10.3B
Stevanato Group S.p.A (STVN)$7.4B
Corcept Therapeutics (CORT)$7.3B
Madrigal Pharmaceuticals (MDGL)$7B
Ionis Pharmaceuticals (IONS)$6.7B
Hikma Pharmaceuticals Plc (HKMPF)$6.2B
Ono Pharmaceutical (OPHLF)$5.2B
Soleno Therapeutics (SLNO)$4.3B
Procaps Group, S.A (PROCF)$3.2B
Hypermarcas (HYPMY)$3B
Crinetics Pharmaceuticals (CRNX)$2.9B
NewAmsterdam Pharma (NAMS)$2.6B
Catalyst Pharmaceuticals (CPRX)$2.5B
AMNEAL PHARMACEUTICALS, INC (AMRX)$2.5B
Centessa Pharmaceuticals (CNTA)$2.2B
Ocular Therapeutix (OCUL)$1.8B
BioCryst Pharmaceuticals (BCRX)$1.8B
ARS Pharmaceuticals (SPRY)$1.7B